Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 6 results:
Author Title [ Type(Desc)] Year
Filters: Author is Ray, K. K.  [Clear All Filters]
Journal Article
K. Khunti, Danese, M. D., Kutikova, L., Catterick, D., Sorio-Vilela, F., Gleeson, M., Seshasai, S. R. Kondapa, Brownrigg, J., and Ray, K. K., Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe, JAMA Netw Open, vol. 1, p. e185554, 2018.
R. Boggon, van Staa, T. P., Timmis, A., Hemingway, H., Ray, K. K., Begg, A., Emmas, C., and Fox, K. A., Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction–a hospital registry-primary care linked cohort (MINAP-GPRD), Eur Heart J, vol. 32, pp. 2376-86, 2011.
M. D. Danese, Gleeson, M., Kutikova, L., Griffiths, R. I., Azough, A., Khunti, K., Seshasai, S. R., and Ray, K. K., Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK, BMJ Open, vol. 6, p. e011805, 2016.
M. D. Danese, Gleeson, M., Kutikova, L., Griffiths, R. I., Khunti, K., Seshasai, S. R. K., and Ray, K. K., Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study, BMJ Open, vol. 7, p. e013851, 2017.
J. R. Brownrigg, Hughes, C. O., Burleigh, D., Karthikesalingam, A., Patterson, B. O., Holt, P. J., Thompson, M. M., de Lusignan, S., Ray, K. K., and Hinchliffe, R. J., Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study, Lancet Diabetes Endocrinol, vol. 4, pp. 588-97, 2016.
C. D. Poole, Halcox, J. P., Jenkins-Jones, S., Carr, E. S., Schifflers, M. G., Ray, K. K., and Currie, C. J., Omega-3 Fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study, Clin Ther, vol. 35, pp. 40-51, 2013.
[Page last reviewed 4 October 2019]